ANDA 88330, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88330 (Lidocaine Hydrochloride), held by Hospira, was first approved by FDA on May 17, 1984, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 17, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride1.5% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Oct 22, 1996 | Supplement 5Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Apr 16, 1985 | Supplement 1Manufacturing | Approved | None posted |
| May 17, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters